Studying the malaria drug tafenoquine in healthy adults
Treatments studied
This study tests how a new malaria drug called tafenoquine moves through the body in healthy adults. It helps provide important safety and dosing information for future use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old and weigh between 132 and 250 pounds.
- Be willing to use contraception during the study if you are of childbearing age.
- Avoid over-the-counter antioxidants, vitamin C, and vitamin E for 2 weeks before and 1 week after taking the study drug.
- Have no major medical conditions such as heart, liver, kidney, or blood disorders.
- Have a normal G6PD blood test (an enzyme that helps red blood cells work).
- Be available for the full study period and not be enrolled in other trials at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the malaria medicine tafenoquine works in healthy children in Papua New Guinea. It may help find the right dose to prevent malaria safely.
This study tests how the malaria medicine tafenoquine is processed in the bodies of young children with vivax malaria. It helps find the right dose for small children and ensures the treatment is safe and effective.
This study tests the best dose of tafenoquine to treat people with symptoms from a malaria type called P. vivax and to help prevent it from coming back. You may be eligible if you recently had fever and meet specific blood and safety checks, especially G6PD level.
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
This study tests an oral medication, tafenoquine, to see if it helps people with chronic babesiosis who have ongoing fatigue and other symptoms. It aims to find a better treatment for this tick-borne infection that keeps coming back.
This trial tests a medicine called tafenoquine, which is used to treat malaria. It aims to see how well it works in children with uncomplicated malaria, and participants will also receive standard malaria treatments.
Hear when a new Pharmacokinetic in Normal Population trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.